Besides Ph+ ALL, other lymphoblastic leukemias can respond to ABL inhibitors, such as T-ALL expressing the NUP214-ABL1 fusion, but again, relapses are frequent. Here, ABL1 is linked to acute lymphoblastic leukemia.